Havas Health & You (HH&Y) announced Thursday that it is launching Archipelago, a standalone value and access consultancy.
Archipelago is slated to work with life sciences clients to optimize market access solutions and help patients “live healthier lives.”
The global offering features a team that has experience dealing with issues relating to payers, pharma, marketing agencies as well as clinical practice settings. The outfit also has experience across a range of therapeutic areas and acquisition models, HH&Y noted, including “chronic, small molecule, buy-and-bill, gene, orphan and digital health.”
Additionally, Archipelago is a global division of Havas Gemini, the value and access center of excellence for HH&Y, and will be led by Michael Pill, who will serve as managing partner.
A company press release noted that the consultancy has already completed more than 50 value and access strategy engagements for early- to late-stage brands.
“Standing at the intersection of the wants and needs of providers, patients, and payers is a dynamic access and reimbursement environment that will significantly impact the success of a brand,” Pill said in a statement. “Archipelago leverages unique expertise to provide clients with actionable strategies that create value, address barriers to access, and improve the human condition by getting appropriate patients on the therapeutic interventions they need to live a healthier life.”
Donna Murphy, CEO of Havas Creative Group as well as HH&Y, added that Archipelago is well-positioned to to leverage its experience and expertise to “solve complex market and brand problems.”
The debut of Archipelago comes weeks after H/Advisors, the global strategic advisory arm of the Havas Network, announced the launch of H/Advisors Public Affairs, a fully integrated healthcare public affairs offering.
As part of the new operation, Mark Twigg, CEO of H/Advisors Cicero, will lead H/Advisors in the U.K. and European Union while Mike Hotra, managing director of H/Advisors Abernathy will lead the firm in the U.S.
Beyond its consultancy and public affairs offerings, HH&Y also unveiled a strategic partnership with Trinity Life Sciences at the J.P. Morgan Healthcare Conference and announced the launch of the ParkinSex wellness campaign with the American Parkinson Disease Association.
